General MedicationsORALGeneric
STAVUDINE
STAVUDINE
Standard Dose
15MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview STAVUDINE is listed in Drugs@FDA under application 079069 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient STAVUDINE Form and strength CAPSULE;ORAL - 15MG Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2020-12-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview STAVUDINE is listed in Drugs@FDA under application 079069 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient STAVUDINE Form and strength CAPSULE;ORAL - 15MG Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2020-12-02 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.